Riskpilot← Back to searchSign inGet full accessSOMMERBORG AS
ASActiveOrg 921677391Glassverkveien 52, 1363 HøvikManufacture of pharmaceutical preparations · NACE 2120Est. 20180 employees
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
72.8%
Financial strength
Net profit 2024
NOK 548
0 employees
| Revenue | NOK 0 | — |
| EBITDA | NOK 0 | — |
| Net profit | NOK 548 | — |
| Total assets | NOK 15K | -95% |
| Equity | NOK 11K | -64% |
| Employees | 0 | — |
Legal name
SOMMERBORG AS
Org number
921677391
Legal form
Aksjeselskap
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
6. november 2018
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene. Daglig leder og styrets leder i fellesskap.
Company purpose
Investering i andre selskap.
Address
Glassverkveien 52, 1363 Høvik
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −6 | −2 | 0 | 0 | 0 | 0 | 0 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −6 | −2 | 0 | 0 | 0 | 0 | 0 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −6 | −2 | 0 | 0 | 0 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −1 |
| Net profit | −6 | −2 | 0 | 0 | 0 | 0 | 1 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 60 | 258 | 303 | 311 | 303 | 303 | 15 |
| Equity | 24 | 23 | 30 | 30 | 30 | 30 | 11 |
| Long-term debt | 0 | 236 | 281 | 281 | 281 | 281 | 4 |
| Short-term debt | 36 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total debt | 36 | 236 | 281 | 281 | 281 | 281 | 4 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20182024
Equity ratio
72.8%
This company
38.2%
Market median
+91% vs market
20182024
Return on equity
5.1%
This company
18.4%
Market median
-72% vs market
20182024
Net profit margin
54800.0%
This company
8.1%
Market median
+676443% vs market
20182024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182024
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
20182024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-10-12 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RH Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2018 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SOMMERBORG AS 
Medelle AsBoard members of SOMMERBORG AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Richard Harborg | Chief Executive Officer | 0 companies |
| Iselin Sommereng | Chairman | 0 companies |